Cargando…
Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis
BACKGROUND: Approximately 5.0–24.2% of colorectal cancers (CRCs) have inactivating mutations in SMAD4, making it one of the frequently mutated genes in CRC. We thus carried out a comprehensive system review and meta-analysis investigating the prognostic significance and clinicopathological features...
Autores principales: | Fang, Tian, Liang, Tingting, Wang, Yizhuo, Wu, Haitao, Liu, Shuhan, Xie, Linying, Liang, Jiaying, Wang, Chang, Tan, Yehui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299661/ https://www.ncbi.nlm.nih.gov/pubmed/34301194 http://dx.doi.org/10.1186/s12876-021-01864-9 |
Ejemplares similares
-
An Early-Onset Advanced Rectal Cancer Patient With Increased KRAS Gene Copy Number Showed A Primary Resistance to Cetuximab in Combination With Chemotherapy: A Case Report
por: Fang, Tian, et al.
Publicado: (2021) -
Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma
por: Yoo, Seung-Yeon, et al.
Publicado: (2019) -
Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms
por: Jiang, Mengjie, et al.
Publicado: (2017) -
Clinicopathologic Features and Prognosis of BRAF Mutated Colorectal Cancer Patients
por: Guan, Wen-Long, et al.
Publicado: (2020) -
The association between SMAD7 polymorphisms and colorectal cancer susceptibility as well as clinicopathological features in the Iranian population
por: Akbari, Zahra, et al.
Publicado: (2020)